329 related articles for article (PubMed ID: 4169552)
1. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
2. Ophthalmopathy of Graves' disease: a comparison between patients treated surgically and patients treated with radioiodide.
Hamilton RD; Mayberry WE; McConahey WM; Hanson KC
Mayo Clin Proc; 1967 Dec; 42(12):812-8. PubMed ID: 5630560
[No Abstract] [Full Text] [Related]
3. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
4. Management of the active severe eye changes of Graves' disease.
Werner SC
Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401
[No Abstract] [Full Text] [Related]
5. [Biological investigation in hyperthyroidism].
Guinet P
Cah Med; 1972 Dec; 13(17):1235-42. PubMed ID: 4121374
[No Abstract] [Full Text] [Related]
6. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
7. Attempt at thyroid ablation with radioactive iodine for the treatment of ophthalmopathy in Graves' disease.
Fawell WN; Catz B
Am J Med Sci; 1973 Jun; 265(6):467-72. PubMed ID: 4740469
[No Abstract] [Full Text] [Related]
8. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
PINCHERA A; PINCHERA MG; STANBURY JB
J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
[No Abstract] [Full Text] [Related]
9. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
10. [Radiotherapy of Basedow's disease].
Torizuka K
Nihon Rinsho; 1971 May; 29(5):1382-7. PubMed ID: 5108763
[No Abstract] [Full Text] [Related]
11. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
12. Thyroid physiology and functional tests.
Zellmann HE
Major Probl Clin Surg; 1974; 15(0):55-70. PubMed ID: 4138680
[No Abstract] [Full Text] [Related]
13. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
Letonturier P; Tourneur R; Sénécal P
Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
[No Abstract] [Full Text] [Related]
14. Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
Werner SC; Feind CR; Aida M
N Engl J Med; 1967 Jan; 276(3):132-8. PubMed ID: 6071187
[No Abstract] [Full Text] [Related]
15. [Combination of low doses of iodine 131 and synthetic antithyroid drugs in long-term care of Basedow's disease. Its value in the prevention of secondary hypothyroidism. (Apropos of 165 cases)].
Jaffiol C; Baldet L; Ghachem M; Robin M; Mirouze J
Sem Hop; 1973 Feb; 49(10):683-92. PubMed ID: 4122346
[No Abstract] [Full Text] [Related]
16. CURRENT METHODS OF DIAGNOSIS AND MANAGEMENT OF GOITER.
MCCULLAGH EP
Cleve Clin Q; 1964 Apr; 31():85-99. PubMed ID: 14141718
[No Abstract] [Full Text] [Related]
17. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
[No Abstract] [Full Text] [Related]
18. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
[No Abstract] [Full Text] [Related]
19. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
20. [Thyrotoxicosis].
Nagata I
Naika Hokan; 1970 Dec; 17(12):459-77. PubMed ID: 4099951
[No Abstract] [Full Text] [Related]
[Next] [New Search]
